Biohaven Balance Sheet Health
Financial Health criteria checks 6/6
Biohaven has a total shareholder equity of $383.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $582.6M and $198.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$436.95m |
| Equity | US$383.74m |
| Total liabilities | US$198.90m |
| Total assets | US$582.64m |
Recent financial health updates
We're Keeping An Eye On Biohaven's (NYSE:BHVN) Cash Burn Rate
Apr 06
Here's Why We're Watching Biohaven's (NYSE:BHVN) Cash Burn Situation
Dec 04Here's Why We're Watching Biohaven's (NYSE:BHVN) Cash Burn Situation
Jul 22Will Biohaven (NYSE:BHVN) Spend Its Cash Wisely?
Apr 06Recent updates
Biohaven: A Complicated Tale
Oct 11Biohaven: Positive SCA Treatment Data Leads To Q4 2024 NDA Submission Catalyst
Sep 23Biohaven: Taldefgrobep Alfa Might Have A Place Beyond SMA Treatment
Jul 26Biohaven: Promising Pipeline With Troriluzole, Taldefgrobep Alfa, And BHV-7000 Leading The Charge
May 18We're Keeping An Eye On Biohaven's (NYSE:BHVN) Cash Burn Rate
Apr 06Calculating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
Mar 01Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade)
Feb 28Biohaven Ltd.: Too Far, Too Fast (Rating Downgrade)
Dec 08Here's Why We're Watching Biohaven's (NYSE:BHVN) Cash Burn Situation
Dec 04Biohaven: Soaring Share Price On New Data Could Be Too Good To Be True
Sep 27Biohaven's Valuation Challenge: Weighing Potential Against Setbacks
Aug 28Here's Why We're Watching Biohaven's (NYSE:BHVN) Cash Burn Situation
Jul 22Biohaven: A Promising Investment In Innovative Neurological Therapies
Jun 14Biohaven: Spinout's Rampant Share Price Gains May Be Giving Pfizer A Headache
Jun 06Will Biohaven (NYSE:BHVN) Spend Its Cash Wisely?
Apr 06Biohaven's spinal muscular atrophy therapy gets FDA fast track status
Feb 21Biohaven Ltd: Assessing The Spinoff
Dec 07Biohaven Non-GAAP EPS of -$1.25
Nov 09Financial Position Analysis
Short Term Liabilities: BHVN's short term assets ($511.3M) exceed its short term liabilities ($156.2M).
Long Term Liabilities: BHVN's short term assets ($511.3M) exceed its long term liabilities ($42.7M).
Debt to Equity History and Analysis
Debt Level: BHVN is debt free.
Reducing Debt: BHVN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BHVN has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BHVN is forecast to have sufficient cash runway for 9 months based on free cash flow estimates, but has since raised additional capital.